ASCO 2026: Genomics Reveal HRD–Treatment Response Link - Top-Institutions - MDSpire

ASCO 2026: Genomics Reveal HRD–Treatment Response Link

Gene expression profiling links HRD in patients with high risk breast cancer with anthracycline outcomes

  • June 5, 2026

  • 2 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    Mass General Brigham Cancer Institute
    Mass General Brigham Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

  • #2

    Center for Cancer Genomics and Advanced Therapeutics
    Center for Cancer Genomics and Advanced Therapeutics

    N/A, N/A

    Key Differentiators

    • Genomics
    • Oncology

  • #3

    Institut Gustave Roussy
    Institut Gustave Roussy

    Villejuif, Île-de-France

    Key Differentiators

    • Oncology

Original Source(s)

ASCO 2026: Genomics Reveal HRD–Treatment Response Link

  • June 5, 2026

Related Content

HiGATE: hierarchical graph attention for multi-scale tissue encoder in computational pathology

Why We Made a Mobile Digital Pathology Lab

Todd R. Minnigh and his team created ScanVan to address a problem with rare cancer diagnosis that had a particularly personal significance

Immune-excluded and immune-suppressive tumor microenvironments: mechanisms, spatial biomarkers, and therapeutic rewiring